Success Story: EB-1B Approval in Just 6 Days for a Biostatistics Research Assistant Professor
Client’s Testimonial:
"I had a great time working with the firm."
On January 29th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Assistant Professor in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Research Assistant Professor
Country of Origin: Taiwan
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: January 29th, 2026
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an I-140 EB-1B (Outstanding Professor or Researcher) approval completed in just 6 days through Premium Processing requested at the time of filing. The client is a biostatistics researcher with a Ph.D. in mathematics, and the petition presented a clear record of original contributions, sustained scholarly output, and trusted peer recognition in an academic setting.
Research Focus and Contributions:
The client has made substantial contributions to the field of biostatistics, with specialized research focused on socioenvironmental factors of healthcare. In the petition, we explained how this work helps clarify how external conditions contribute to variations in care outcomes and risky health behaviors, and why improved statistical methodology is essential for drawing accurate conclusions from complex biomedical and public health data.
We highlighted the client’s originality through a cohesive set of contributions, including innovative methodological work for complex data settings, advanced computational and analytical approaches that support timely and reliable evaluation of clinical outcomes, and data-driven research that identifies and addresses disparities in healthcare across diverse patient populations. Rather than presenting these topics as separate projects, we demonstrated that they form a consistent research arc: building rigorous methods that make biomedical findings more reliable and more usable for clinical and public health decision-making.
At the time of filing, the client had produced 25 peer-reviewed journal articles, 2 peer-reviewed conference articles, and 36 abstracts. The client’s work had been cited 97 times. We did not present these metrics as automatically sufficient. Instead, we explained how an adjudicator could reasonably interpret them in context.
The petition also documented that the client had conducted at least 17 peer reviews. We framed this as a separate trust indicator because journals typically invite reviewers who have demonstrated recognized expertise and sound judgment, especially when evaluating technical work in biostatistics and allied biomedical areas.
The client is currently employed as a research assistant professor at a U.S. academic medical institution, where the role involves developing and applying advanced statistical methods to analyze complex biomedical and public health data. This helped reinforce that the client is actively positioned to continue producing influential research in the United States.
Support from Experts in the Field:
To further substantiate the client’s standing, the petition included 4 letters of recommendation from established experts. These letters helped translate specialized methodological contributions into tangible, real-world significance and corroborated the objective evidence of publications, citations, and peer-review activity.
One expert noted:
“Her remarkable works, active role in the peer review process, and extensive citation record establish [Client] as a uniquely valuable figure in the field of biostatistics and the global community.”
EB-1B Approval and Outlook:By organizing the evidence around original research contributions, independent reliance shown through citations, and trusted peer recognition demonstrated through peer review and expert support, we presented a persuasive EB-1B record. USCIS approved the petition in 6 days through Premium Processing. We are proud to have guided this client to success and look forward to the client’s continued contributions to biostatistical methods that strengthen healthcare research and evidence-based decision-making in the United States.